| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9388cb841605d5dcfeb6bc6d60f4384a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2022-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01faa7b70149021f8330113751a744c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b7acdae63b096f13d2daeef0eb765a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a679076bb510445e0e93f641ec65d7f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817a56bedf0c84eff5aa6865060dfd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58e0f97d21752f6289ca973624e3684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2abd9e5cf27e0a6475374cd05b0a439a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95615eece42702bc4c1e5354101e6f67 |
| publicationDate |
2022-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022282336-A1 |
| titleOfInvention |
Biomarkers for non-hodgkin lymphomas and uses thereof |
| abstract |
The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers. |
| priorityDate |
2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |